SL
ABBV icon

Summitry LLC’s AbbVie ABBV Stock Holding History

Summitry LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Buy
4,563
+569
+14% +$122K 0.04% 88
2026
Q1 		$869K Sell
3,994
-212
-5% -$47K 0.03% 90
2025
Q4 		$961K Buy
4,206
+96
+2% +$21.9K 0.04% 71
2025
Q3 		$952K Buy
4,110
+1,064
+35% +$217K 0.04% 67
2025
Q2 		$565K Sell
3,046
-548
-15% -$102K 0.03% 87
2025
Q1 		$753K Buy
3,594
+69
+2% +$13.4K 0.04% 63
2024
Q4 		$626K Sell
3,525
-638
-15% -$117K 0.03% 67
2024
Q3 		$822K Buy
4,163
+1,545
+59% +$288K 0.04% 65
2024
Q2 		$449K Sell
2,618
-320
-11% -$53K 0.02% 71
2024
Q1 		$535K Sell
2,938
-955
-25% -$165K 0.03% 66
2023
Q4 		$603K Buy
3,893
+15
+0.4% +$2.19K 0.04% 65
2023
Q3 		$578K Sell
3,878
-28
-0.7% -$4.11K 0.04% 61
2023
Q2 		$526K Sell
3,906
-24
-0.6% -$3.52K 0.03% 65
2023
Q1 		$626K Sell
3,930
-27
-0.7% -$4.13K 0.04% 64
2022
Q4 		$639K Sell
3,957
-102
-3% -$15.6K 0.05% 63
2022
Q3 		$545K Buy
4,059
+670
+20% +$96.1K 0.04% 69
2022
Q2 		$519K Hold
3,389
– – 0.04% 62
2022
Q1 		$549K Hold
3,389
– – 0.03% 65
2021
Q4 		$459K Buy
+3,389
New +$400K 0.03% 68
2021
Q2 		– Sell
-4,080
Closed -$442K – 55
2021
Q1 		$442K Sell
4,080
-8
-0.2% -$856 0.03% 71
2020
Q4 		$438K Buy
4,088
+307
+8% +$29.5K 0.03% 68
2020
Q3 		$331K Sell
3,781
-290
-7% -$27.3K 0.03% 73
2020
Q2 		$400K Buy
+4,071
New +$358K 0.03% 68

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Summitry LLC's ABBV Position: Q2 2026 in Review

Summitry LLC increased its AbbVie (ABBV) stake by 14% in Q2 2026, buying an estimated $122K and bringing the position to 4,563 shares worth $1.15M. The position accounts for 0.04% of the portfolio, ranked #88.

Summitry LLC first reported a position in ABBV in Q2 2020 and has held it in 23 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Summitry LLC held 4,563 shares of AbbVie worth $1.15M as of Q2 2026.
  • Summitry LLC bought 569 AbbVie shares in Q2 2026, an estimated $122K.
  • AbbVie made up 0.04% of Summitry LLC's portfolio in Q2 2026, its #88 holding.
  • Summitry LLC first reported a position in AbbVie in Q2 2020 and has held it in 23 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Summitry LLC's 13F filing for Q2 2026, filed 21 Jul 2026.